somewhat arbitrary. In the literature there are various variants of bases of orthogonal log-transformation of the data, but there are no ecologically well-founded criteria for their choice
Objective: Log-transformations are commonly used to normalize chemical data. However, log-transformations do not always normalize the data. Thus, the objective of this study was to recursively use Tukey ... properties…
analysis using Kinetica? program V 4.2 using all phases. The 90 % confidence intervals for log-transformed AUC0 -t and Cmax were calculated for phases I & II; then for phases
spectrometry method. The 90% confidence intervals for the geometric least squares mean ratios of log-transformed AUC0-tlast, AUC0-∞ and Cmax for the single-dose studies and log-transformed
size calculation methods based on the negative binomial distribution using the Wald test, the log-transformed Wald test and the log-likelihood ratio test statistics. A comparison of our five ... also estimated via the…
Exposure was similar with 90% CI limits for the geometric mean ratios of log-transformed AUC0-t that were within the 80%-125% equivalence range. Day 4 partial AUC0
succession rate was estimated by the slopes (w values) of linear regression of a log-transformed microbial community similarity with time (time–decay relationship). Compared with the low turnover rate
unchanged GLIM. Bioequivalence was assessed by analysis of variance (ANOVA) using natural log-transformed Cmax and AUC values. The time courses of plasma concentrations of unchanged PIO and GLIM were ... coadministered…
Spray mode. Pharmacokinetic parameters AUC0-t, AUC0-∞ and Cmax were tested for bioequivalence after log-transformation of data and ratios of tmax were evaluated non-parametrically. Results: The point estimates
data explained by the relationship between locations and transect. Additionally, means extracted from log-transformed data suggest that the twelve percent decrease in live coral between transects of the healthy
spectrometry method. Pharmacokinetic parameters AUC0-t, AUC0-∞ and Cmax were tested for bioequivalence after log-transformation of data and ratios of tmax were evaluated. Result: The point estimates
formulations were considered to be bioequivalent if the 90% CIs for the log-transformed values were within the predetermined equivalence range (80%–125% for AUC and Cmax). For clopidogrel ... log-transformed ratios of…
post dose. The 90% confi dence intervals constructed for the ratios of means of log-transformed partial AUC (at 72hrs and 2 half-lives post dose) were compared individually with ... observed. The 90% confi dence…
AUC00, and Cmax were not always in agreement with the 90 % confidence intervals for log-transformed truncated AUC. More over, the 90 % confidence intervals for log-transformed AUC0 -t, AUC00
calculating 90% Confidence Intervals (CIs) for the geometric least squares mean ratio of log-transformed primary parameters (AUC0-tlast, AUC0-∞ and Cmax) between the test and reference products
geometric least squares mean ratio between the formulations of log-transformed AUC0-72h and Cmax were 95.82-107.00% and 95.40-122.32%, respectively which were within the acceptance range for bioequivalence
mode. Pharmacokinetic parameters of AUC0-t, AUC0-∞and Cmax were tested for bioequivalence after log-transformation of data and ratios of tmax was evaluated non-parametrically. The estimated points
observed around the globe during the study period. In the analysis, the log-transformed value of the series was considered, and relatively stable variations were found around the mean
means cluster analysis to classify the 69 patients into two distinct groups by the log-transformed EEG powers (4 frequency bands x 19 channels) for the three EEG segments
observed were mostly due to size distribution rather than the ecological differences between stations. Log-transformed regression relationships between body burden and size were used to compare the species. Relationship
tmax, t1/2el were estimated to prove bioequivalence. The confidence intervals for the log-transformed Test/Reference Ratios for alfuzosin 110.65 (98.01-124.93) % and 111.98 (101.87-123.10) % for Cmax
study has potential limitations. A random effects model has been estimated considering log-transformed data seeking to obtain reliable measurements that allow a statistical analysis. The estimate model has conducted
tmax, t1/2el were estimated to prove bioequivalence. The confidence intervals for the log-transformed test/reference ratios for dalfampridine 100.96 (97.09-104.97%) and 99.77 (95.81-103.87%) for Cmax
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.